FIP1L1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.858200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.343400E-01
Normal-vs-Stage2
5.844000E-01
Normal-vs-Stage3
2.875600E-01
Normal-vs-Stage4
4.260800E-01
Stage1-vs-Stage2
5.776200E-01
Stage1-vs-Stage3
3.425600E-01
Stage1-vs-Stage4
1.648400E-01
Stage2-vs-Stage3
3.204200E-01
Stage2-vs-Stage4
4.126400E-02
Stage3-vs-Stage4
8.721800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.991200E-01
Normal-vs-AfricanAmerican
8.272600E-01
Normal-vs-Asian
2.380400E-01
Caucasian-vs-AfricanAmerican
6.789800E-01
Caucasian-vs-Asian
3.468600E-01
AfricanAmerican-vs-Asian
2.414800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.418000E-01
Normal-vs-Female
6.350600E-01
Male-vs-Female
9.105600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.250200E-01
Normal-vs-Age(41-60Yrs)
9.895800E-01
Normal-vs-Age(61-80Yrs)
3.873600E-01
Normal-vs-Age(81-100Yrs)
3.177000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.549000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.052400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.634600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.368040E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.738300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.676800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.105000E-01
Normal-vs-Daily Drinker
2.087200E-01
Normal-vs-Weekly Drinker
9.776000E-01
Normal-vs-Occasional Drinker
7.283600E-01
Normal-vs-Social Drinker
3.954600E-01
Non Drinker-vs-Daily Drinker
7.283600E-01
Non Drinker-vs-Weekly Drinker
3.574600E-01
Non Drinker-vs-Occasional Drinker
1.279820E-01
Non Drinker-vs-Social Drinker
6.178600E-01
Daily Drinker-vs-Weekly Drinker
2.891000E-01
Daily Drinker-vs-Occasional Drinker
6.118200E-02
Daily Drinker-vs-Social Drinker
4.043800E-01
Weekly Drinker-vs-Occasional Drinker
8.123000E-01
Weekly Drinker-vs-Social Drinker
4.973400E-01
Occasional Drinker-vs-Social Drinker
3.339800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.068200E-01
Normal-vs-Grade 2
7.491800E-01
Normal-vs-Grade 3
7.651800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.178100E-02
Grade 1-vs-Grade 3
2.356300E-02
Grade 1-vs-Grade 4
7.068200E-01
Grade 2-vs-Grade 3
3.676000E-01
Grade 2-vs-Grade 4
7.491800E-01
Grade 3-vs-Grade 4
7.651800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.094600E-01
Normal-vs-NonDiabetic
5.725400E-01
Diabetic-vs-NonDiabetic
2.834400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.670000E-01
Normal-vs-NoPancreatitis
5.441400E-01
Pancreatitis-vs-NoPancreatitis
8.083000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.526200E-01
Normal-vs-N1
6.004600E-01
N0-vs-N1
6.780600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.450800E-01
Normal-vs-TP53-NonMutant
4.971400E-01
TP53-Mutant-vs-TP53-NonMutant
1.484210E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
